Amiodarone-induced diffuse alveolar haemorrhage: A rare but potentially life-threatening complication of a commonly prescribed medication

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Amiodarone is an antiarrhythmic agent that is used commonly in clinical practice. It is associated with many side effects, the most common being pulmonary manifestations. Interstitial pneumonitis is one of the most common complications, however rarely amiodarone can cause diffuse alveolar haemorrhage (DAH) too. We describe the case of a 73-year-old woman who presented with shortness of breath and haemoptysis 4 days after starting amiodarone. She was diagnosed with amiodarone-induced DAH based on imaging and bronchoalveolar lavage. She was treated with intravenous and then oral steroids, and amiodarone was discontinued. The patient made a significant clinical and radiological recovery. She was discharged 10 days after her presentation. This case highlights a rare but potentially life-threatening complication of a commonly used medication.

Cite

CITATION STYLE

APA

Saeed, J., Waqas, Q. A., Khan, U. I., & Abdullah, H. M. A. (2019). Amiodarone-induced diffuse alveolar haemorrhage: A rare but potentially life-threatening complication of a commonly prescribed medication. BMJ Case Reports, 12(10). https://doi.org/10.1136/bcr-2019-232149

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free